Toronto, Ontario--(Newsfile Corp. - January 12, 2017) - Aumento Capital V Corporation (TSXV: AMN.P) ("Aumento" or the
"Corporation") wishes to announce that a shareholder of Aumento intends to bring forth a special resolution at the
Corporation's upcoming special meeting of shareholders (the "Shareholders Meeting"), currently scheduled to be held on
January 23, 2017, to set the number of directors of Aumento at six, an increase from the current number of three. It is further
anticipated that at the Shareholders Meeting it will be proposed that the three additional directors of the Corporation will be
appointed concurrently with the closing of the Corporation's previously announced qualifying transaction (the "Transaction")
with WeedMD RX Inc. ("WMD"). The Transaction will result in the reverse take-over of the Corporation by the shareholders of
WMD. The names and background information of the additional contingent directors to be appointed at the Shareholders Meeting will
be outlined in a future press release to be issued by Aumento.
About WeedMD RX Inc.
WeedMD is a licensed producer of medical cannabis pursuant to the Access to Cannabis for Medical Purposes Regulations (ACMPR).
WeedMD operates a 25,000 square foot, scalable production facility in Aylmer, Ontario with four acres of property for future
expansion. The Company is focused on providing consistent, quality medicine to the long-term care and assisted living markets in
Canada through its comprehensive platform developed exclusively for that industry. WeedMD is dedicated to educating healthcare
practitioners and furthering public understanding of the role medical cannabis can play as a viable alternative to prescription
medication in relieving a variety of chronic medical conditions and illnesses.
Aumento will issue additional press releases related to the final legal structure of the Transaction, officers and directors of
the resulting issuer, sponsorship and other material information as it becomes available. For further information regarding the
Transaction, please contact:
David Danziger, CEO
david.danziger@mnp.ca
(416) 515-3923
Completion of the transaction is subject to a number of conditions, including but not limited to, TSXV acceptance and,
if applicable, pursuant to the requirements of the TSXV, majority of the minority shareholder approval. Where
applicable, the transaction cannot close until the required shareholder approval is obtained. There can be no assurance that
the transaction will be completed as proposed or at all.
Investors are cautioned that, except as disclosed in the management information circular or filing statement to be
prepared in connection with the transaction, any information released or received with respect to the transaction may not be
accurate or complete and should not be relied upon. Trading in the securities of a capital pool company should be considered
highly speculative.
The TSX Venture Exchange Inc. has in no way passed upon the merits of the proposed transaction and has neither
approved nor disapproved the contents of this press release.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE
TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain "forward-looking statements"
under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with
respect to: the terms and conditions of the proposed Transaction; future developments; the conduct of the Shareholders Meeting and
the business and operations of the resulting issuer after the completion of the proposed Transaction. Forward-looking statements
are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and
unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from
those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business,
economic, competitive, political and social uncertainties; delay or failure to receive shareholder or regulatory approvals; and the
results of continued development, marketing and sales. There can be no assurance that such statements will prove to be accurate, as
actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not
place undue reliance on forward-looking statements. Aumento disclaims any intention or obligation to update or revise any
forward-looking statements, whether as a result of new information, future events or otherwise, except as required by
law.